BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19783142)

  • 1. Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.
    Bhattarai BR; Kafle B; Hwang JS; Khadka D; Lee SM; Kang JS; Ham SW; Han IO; Park H; Cho H
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6161-5. PubMed ID: 19783142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-γ activators.
    Bhattarai BR; Kafle B; Hwang JS; Ham SW; Lee KH; Park H; Han IO; Cho H
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6758-63. PubMed ID: 20850970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mono- and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs.
    Shrestha S; Bhattarai BR; Lee KH; Cho H
    Bioorg Med Chem; 2007 Oct; 15(20):6535-48. PubMed ID: 17692525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors.
    Gupta S; Pandey G; Rahuja N; Srivastava AK; Saxena AK
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5732-4. PubMed ID: 20797859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
    Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationalizing protein-ligand interactions for PTP1B inhibitors using computational methods.
    Ajmani S; Karanam S; Kulkarni SA
    Chem Biol Drug Des; 2009 Dec; 74(6):582-95. PubMed ID: 19824894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual PPAR-alpha and -gamma activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential.
    Madhavan GR; Chakrabarti R; Reddy KA; Rajesh BM; Balraju V; Rao PB; Rajagopalan R; Iqbal J
    Bioorg Med Chem; 2006 Jan; 14(2):584-91. PubMed ID: 16198573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile.
    Xu Y; Etgen GJ; Broderick CL; Canada E; Gonzalez I; Lamar J; Montrose-Rafizadeh C; Oldham BA; Osborne JJ; Xie C; Shi Q; Winneroski LL; York J; Yumibe N; Zink R; Mantlo N
    J Med Chem; 2006 Sep; 49(19):5649-52. PubMed ID: 16970391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity.
    Rocha RF; Rodrigues T; Menegatti ACO; Bernardes GJL; Terenzi H
    Bioorg Chem; 2020 Jul; 100():103927. PubMed ID: 32422389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
    Wang Z; Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3337-40. PubMed ID: 24953600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
    Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B.
    Lin L; Shen Q; Chen GR; Xie J
    Bioorg Med Chem; 2008 Nov; 16(22):9757-63. PubMed ID: 18922697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antihyperglycemic activity profiles of novel thiazolidinedione derivatives.
    Bhat BA; Ponnala S; Sahu DP; Tiwari P; Tripathi BK; Srivastava AK
    Bioorg Med Chem; 2004 Nov; 12(22):5857-64. PubMed ID: 15498661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-O-carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity.
    Bhattarai BR; Shrestha S; Ham SW; Kim KR; Cheon HG; Lee KH; Cho H
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5357-60. PubMed ID: 17728130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydroisoquinoline PPARgamma agonists: design of novel, highly selective non-TZD antihyperglycemic agents.
    Henry JR; Li Y; Warshawsky AM; Brozinick JT; Hawkins ED; Misener EA; Briere DA; Montrose-Rafizadeh C; Zink RW; Yumibe NP; Ajamie RT; Wilken B; Devanarayan V
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6293-7. PubMed ID: 17005393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity.
    Li M; Li H; Min X; Sun J; Liang B; Xu L; Li J; Wang SH; Xu X
    J Med Chem; 2024 May; 67(10):8406-8419. PubMed ID: 38723203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Almanza-Pérez JC; Román-Ramos R; Alarcón-Aguilar FJ; Hernández-Rosado JV; Moreno-Díaz H; Díaz-Coutiño D; Navarrete-Vázquez G
    Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
    Mahapatra MK; Kumar R; Kumar M
    Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones: An In-Depth Study of Their Synthesis and Application to Medicinal Chemistry in the Treatment of Diabetes Mellitus.
    Long N; Le Gresley A; Wren SP
    ChemMedChem; 2021 Jun; 16(11):1716-1735. PubMed ID: 33844475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IKK-beta: a new development in the mechanism of the anti-obesity effects of PTP1B inhibitors SA18 and SA32.
    Bhattarai BR; Ko JH; Shrestha S; Kafle B; Cho H; Kang JH; Cho H
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1075-7. PubMed ID: 20044255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.